| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 47.424.101 $ | 97,15 | 2.132.474 | |||||||
| APOGEE THERAPEUTICS INC | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 706.522 $ | 1,45 | 5.323 | |
| MODERNA INC | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 670.467 $ | 1,37 | 9.574 | |
| TWIST BIOSCIENCE CORP | Twist Bioscience Corporation | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 668.411 $ | 1,37 | 6.497 | |
| ORUKA THERAPEUTICS INC | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 654.389 $ | 1,34 | 6.876 | |
| KYMERA THERAPEUTICS INC | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 645.363 $ | 1,32 | 5.628 | |
| VIKING THERAPEUTICS INC | Viking Therapeutics, Inc. | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 618.933 $ | 1,27 | 15.866 | |
| PRAXIS PRECISION MEDICINES INC | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 612.666 $ | 1,26 | 1.830 | |
| ERASCA INC | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 603.296 $ | 1,24 | 32.931 | |
| REVOLUTION MEDICINES INC | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 571.953 $ | 1,17 | 3.054 | |
| RHYTHM PHARMACEUTICALS INC | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 570.361 $ | 1,17 | 5.137 | |
| CG ONCOLOGY INC | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 569.608 $ | 1,17 | 8.017 | |
| SELLAS LIFE SCIENCES GROUP INC | SELLAS Life Sciences Group, Inc. | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 564.762 $ | 1,16 | 38.263 | |
| VAXCYTE INC | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 563.512 $ | 1,15 | 9.694 | |
| DIANTHUS THERAPEUTICS INC | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 561.582 $ | 1,15 | 5.761 | |
| CYTOKINETICS INC | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 559.272 $ | 1,15 | 6.565 | |
| NATERA INC | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 552.129 $ | 1,13 | 2.034 | |
| SCHOLAR ROCK HOLDING CORP | Scholar Rock Holding Corporation | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 549.230 $ | 1,13 | 9.986 | |
| ROIVANT SCIENCES LTD | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 548.474 $ | 1,12 | 15.498 | |
| MIRUM PHARMACEUTICALS INC | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 548.356 $ | 1,12 | 4.684 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 543.000 $ | 1,11 | 14.031 | |
| ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 541.385 $ | 1,11 | 16.214 | |
| TRAVERE THERAPEUTICS INC | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 535.150 $ | 1,10 | 9.420 | |
| ALKERMES PLC | Alkermes plc | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 526.203 $ | 1,08 | 10.043 | |
| KRYSTAL BIOTECH INC | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 523.683 $ | 1,07 | 1.409 | |
| CELCUITY INC | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 522.054 $ | 1,07 | 4.990 | |
| RELAY THERAPEUTICS INC | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 521.616 $ | 1,07 | 27.879 | |
| SPYRE THERAPEUTICS INC | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 520.606 $ | 1,07 | 5.864 | |
| TG THERAPEUTICS INC | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 519.073 $ | 1,06 | 9.448 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 512.398 $ | 1,05 | 14.930 | |
| PROTAGONIST THERAPEUTICS INC | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 510.301 $ | 1,05 | 4.163 | |
| INSMED INC | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 510.283 $ | 1,05 | 4.786 | |
| ARROWHEAD PHARMACEUTICALS INC | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 507.400 $ | 1,04 | 6.225 | |
| VERA THERAPEUTICS INC | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 502.819 $ | 1,03 | 11.718 | |
| VERTEX PHARMACEUTICALS INC | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 502.194 $ | 1,03 | 1.011 | |
| MADRIGAL PHARMACEUTICALS INC | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 501.511 $ | 1,03 | 934 | |
| ABBVIE INC | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 492.459 $ | 1,01 | 1.957 | |
| BIOGEN INC | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 489.808 $ | 1,00 | 2.267 | |
| PTC THERAPEUTICS INC | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 489.665 $ | 1,00 | 6.003 | |
| HALOZYME THERAPEUTICS INC | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 488.796 $ | 1,00 | 6.245 | |
| UNIQURE NV | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 488.098 $ | 1,00 | 10.597 | |
| BRIDGEBIO PHARMA INC | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 486.503 $ | 1,00 | 6.532 | |
| CRISPR THERAPEUTICS AG | CRISPR Therapeutics A.G. | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 485.733 $ | 1,00 | 8.906 | |
| IMMUNITYBIO INC | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 483.749 $ | 0,99 | 55.254 | |
| SUMMIT THERAPEUTICS INC | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 480.183 $ | 0,98 | 32.957 | |
| IONIS PHARMACEUTICALS INC | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 476.136 $ | 0,98 | 6.005 | |
| INCYTE CORP | Incyte Corporation | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 473.618 $ | 0,97 | 4.178 | |
| AMGEN INC | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 472.204 $ | 0,97 | 1.304 | |
| NEUROCRINE BIOSCIENCES INC | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 461.280 $ | 0,94 | 2.737 | |
| GILEAD SCIENCES INC | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 457.856 $ | 0,94 | 3.624 | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 456.431 $ | 0,94 | 732 | |
| EXELIXIS INC | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 455.629 $ | 0,93 | 8.374 | |
| ALNYLAM PHARMACEUTICALS INC | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 455.157 $ | 0,93 | 1.512 | |
| BIOMARIN PHARMACEUTICAL INC | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 448.548 $ | 0,92 | 7.839 | |
| ACADIA PHARMACEUTICALS INC | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 444.926 $ | 0,91 | 17.586 | |
| NUVALENT INC | Nuvalent, Inc. | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 440.772 $ | 0,90 | 3.569 | |
| IMMUNOVANT INC | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 438.972 $ | 0,90 | 11.393 | |
| UNITED THERAPEUTICS CORP | United Therapeutics Corporation | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 438.340 $ | 0,90 | 809 | |
| INTELLIA THERAPEUTICS INC | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 430.665 $ | 0,88 | 25.453 | |
| GRAIL INC | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 430.306 $ | 0,88 | 6.303 | |
| BIOCRYST PHARMACEUTICALS INC | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 423.670 $ | 0,87 | 42.367 | |
| CATALYST PHARMACEUTICALS INC | Catalyst Pharmaceuticals, Inc. | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 414.876 $ | 0,85 | 13.200 | |
| DYNE THERAPEUTICS INC | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 407.753 $ | 0,84 | 18.359 | |
| TANGO THERAPEUTICS INC | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 399.597 $ | 0,82 | 12.783 | |
| DENALI THERAPEUTICS INC | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 395.239 $ | 0,81 | 15.367 | |
| VERACYTE INC | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 388.616 $ | 0,80 | 6.617 | |
| IDEAYA BIOSCIENCES INC | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 381.347 $ | 0,78 | 10.232 | |
| RECURSION PHARMACEUTICALS INC | Recursion Pharmaceuticals, Inc. | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 359.194 $ | 0,74 | 97.873 | |
| SAREPTA THERAPEUTICS INC | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 354.422 $ | 0,73 | 19.723 | |
| ARCUS BIOSCIENCES INC | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 352.695 $ | 0,72 | 11.440 | |
| SYNDAX PHARMACEUTICALS INC | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 340.950 $ | 0,70 | 15.597 | |
| ARCUTIS BIOTHERAPEUTICS INC | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 337.818 $ | 0,69 | 12.884 | |
| MINERALYS THERAPEUTICS INC | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 336.468 $ | 0,69 | 12.471 | |
| CELLDEX THERAPEUTICS INC | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 333.290 $ | 0,68 | 8.957 | |
| AGIOS PHARMACEUTICALS INC | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 328.980 $ | 0,67 | 8.865 | |
| VIRIDIAN THERAPEUTICS INC | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 318.646 $ | 0,65 | 17.346 | |
| NOVAVAX INC | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 313.573 $ | 0,64 | 33.288 | |
| DISC MEDICINE INC | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 309.967 $ | 0,63 | 4.238 | |
| ADMA BIOLOGICS INC | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 288.363 $ | 0,59 | 34.452 | |
| IMMUNOME INC | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 281.107 $ | 0,58 | 13.266 | |
| PALVELLA THERAPEUTICS INC | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 276.910 $ | 0,57 | 1.812 | |
| IOVANCE BIOTHERAPEUTICS INC | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 267.322 $ | 0,55 | 64.260 | |
| ABSCI CORP | Absci Corporation | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 265.736 $ | 0,54 | 22.928 | |
| NURIX THERAPEUTICS INC | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 264.531 $ | 0,54 | 10.904 | |
| KODIAK SCIENCES INC | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 258.305 $ | 0,53 | 6.630 | |
| BIOHAVEN LTD | Biohaven Ltd. | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 250.103 $ | 0,51 | 16.808 | |
| VERICEL CORP | Vericel Corporation | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 235.575 $ | 0,48 | 5.295 | |
| ANAPTYSBIO INC | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 235.373 $ | 0,48 | 3.487 | |
| CAPRICOR THERAPEUTICS INC | Capricor Therapeutics, Inc. | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 231.890 $ | 0,48 | 9.630 | |
| STOKE THERAPEUTICS INC | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 228.287 $ | 0,47 | 6.977 | |
| MONTE ROSA THERAPEUTICS INC | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 226.802 $ | 0,46 | 9.372 | |
| VIR BIOTECHNOLOGY INC | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 223.436 $ | 0,46 | 21.927 | |
| HYPERLIQUID STRATEGIES INC | Hyperliquid Strategies, Inc. | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 220.856 $ | 0,45 | 28.063 | |
| TYRA BIOSCIENCES INC | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 197.166 $ | 0,40 | 6.173 | |
| CORVUS PHARMACEUTICALS INC | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 194.190 $ | 0,40 | 12.998 | |
| CULLINAN THERAPEUTICS INC | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 191.970 $ | 0,39 | 10.542 | |
| PRECIGEN INC | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 179.066 $ | 0,37 | 31.415 | |
| INHIBRX BIOSCIENCES INC | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 168.466 $ | 0,35 | 1.778 | |
| TAYSHA GENE THERAPIES INC | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 168.044 $ | 0,34 | 24.676 | |
| ARDELYX INC | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 167.708 $ | 0,34 | 32.884 | |
| AVALO THERAPEUTICS INC | Avalo Therapeutics, Inc. | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 166.283 $ | 0,34 | 8.998 | |
| MANNKIND CORP | MannKind Corporation | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 160.879 $ | 0,33 | 37.765 | |
| ANNEXON INC | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 157.819 $ | 0,32 | 27.639 | |
| ORIC PHARMACEUTICALS INC | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 156.786 $ | 0,32 | 14.477 | |
| ZENAS BIOPHARMA INC | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 151.849 $ | 0,31 | 5.983 | |
| JADE BIOSCIENCES INC | Jade Biosciences, Inc. | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 151.096 $ | 0,31 | 6.800 | |
| OLEMA PHARMACEUTICALS INC | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 150.695 $ | 0,31 | 12.046 | |
| KURA ONCOLOGY INC | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 149.576 $ | 0,31 | 13.635 | |
| CAREDX INC | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 144.467 $ | 0,30 | 5.069 | |
| BICARA THERAPEUTICS INC | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 144.353 $ | 0,30 | 4.862 | |
| VOR BIOPHARMA INC | Vor BioPharma, Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 143.340 $ | 0,29 | 7.786 | |
| XENCOR INC | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 138.460 $ | 0,28 | 8.600 | |
| ARRIVENT BIOPHARMA INC | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 135.104 $ | 0,28 | 3.889 | |
| REPLIMUNE GROUP INC | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 134.810 $ | 0,28 | 12.178 | |
| CYTOMX THERAPEUTICS INC | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 132.413 $ | 0,27 | 35.310 | |
| JANUX THERAPEUTICS INC | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 131.328 $ | 0,27 | 8.550 | |
| SIONNA THERAPEUTICS INC | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 126.339 $ | 0,26 | 2.872 | |
| GERON CORP | Geron Corporation | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 123.813 $ | 0,25 | 96.729 | |
| SOLID BIOSCIENCES INC | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 114.376 $ | 0,23 | 11.449 | |
| RIGEL PHARMACEUTICALS INC | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 112.783 $ | 0,23 | 2.883 | |
| ALLOGENE THERAPEUTICS INC | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 111.983 $ | 0,23 | 53.838 | |
| SANA BIOTECHNOLOGY INC | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 109.513 $ | 0,22 | 31.379 | |
| ALTIMMUNE INC | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 109.130 $ | 0,22 | 35.898 | |
| REGENXBIO INC | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 104.046 $ | 0,21 | 8.685 | |
| IRONWOOD PHARMACEUTICALS INC | Ironwood Pharmaceuticals, Inc. | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 102.661 $ | 0,21 | 24.385 | |
| IMMIX BIOPHARMA INC | Immix Biopharma, Inc. | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 96.182 $ | 0,20 | 9.329 | |
| OCUGEN INC | Ocugen Inc | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 94.877 $ | 0,19 | 62.011 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 94.856 $ | 0,19 | 7.132 | |
| CANDEL THERAPEUTICS INC | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 92.422 $ | 0,19 | 8.973 | |
| SAVARA INC | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 87.293 $ | 0,18 | 14.171 | |
| PRIME MEDICINE INC | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 85.505 $ | 0,18 | 23.172 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 82.995 $ | 0,17 | 4.125 | |
| DAMORA THERAPEUTICS INC | Damora Therapeutics, Inc. | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 82.452 $ | 0,17 | 3.170 | |
| ARS PHARMACEUTICALS INC | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 81.221 $ | 0,17 | 10.140 | |
| MAPLIGHT THERAPEUTICS INC | MapLight Therapeutics, Inc. | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 79.206 $ | 0,16 | 2.210 | |
| ARBUTUS BIOPHARMA CORP | Arbutus Biopharma Corporation | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 78.221 $ | 0,16 | 16.296 | |
| MYRIAD GENETICS INC | Myriad Genetics, Inc. | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 76.343 $ | 0,16 | 13.370 | |
| CABALETTA BIO INC | Cabaletta Bio Inc | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 72.475 $ | 0,15 | 23.304 | |
| COMPASS THERAPEUTICS INC | Compass Therapeutics, Inc. | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 66.412 $ | 0,14 | 30.325 | |
| EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions, Inc. | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 63.395 $ | 0,13 | 7.565 | |
| PROTHENA CORP PLC | Prothena Corp plc | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 63.077 $ | 0,13 | 6.443 | |
| VANDA PHARMACEUTICALS INC | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 62.185 $ | 0,13 | 10.161 | |
| PERSPECTIVE THERAPEUTICS INC | Perspective Therapeutics, Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 61.022 $ | 0,13 | 17.895 | |
| OVID THERAPEUTICS INC | Ovid therapeutics, Inc. | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 58.685 $ | 0,12 | 21.816 | |
| VERASTEM INC | Verastem, Inc. | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 57.399 $ | 0,12 | 15.026 | |
| MIMEDX GROUP INC | MiMedx Group, Inc. | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 50.474 $ | 0,10 | 13.110 | |
| LEXEO THERAPEUTICS INC | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 50.144 $ | 0,10 | 10.772 | |
| ACHIEVE LIFE SCIENCES INC | Achieve Life Sciences Inc | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 39.082 $ | 0,08 | 5.985 | |
| SAGIMET BIOSCIENCES INC | Sagimet Biosciences, Inc. | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 33.695 $ | 0,07 | 4.359 | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BridgeBio Oncology Therapeutics, Inc. | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 27.478 $ | 0,06 | 3.606 | |
| 47.424.101 $ | 97,15 | 2.132.474 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.